In HPV-negative HNSCC, TP53 is commonly inactivated by mutation or deletion [114], while the HPV oncoproteins inactivate p53 by biochemical mechanisms in HPV-positive HNSCC. Here, TP53 is linked to head and neck squamous cell carcinoma.